← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 10, 2021Last known activity
Jun 17, 2025
Timeline
2010s
- Jun 1, 2019
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.— Founded
Drugs by trial phase (8 distinct, 12 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (20)
- NCT07011797Lead sponsorPhase 2Jun 17, 2025
- NCT06990867OfficialPhase 2/Phase 3May 15, 2025
- NCT06990867Lead sponsorPhase 2/Phase 3May 15, 2025
- NCT06270030OfficialPhase 1Mar 4, 2024
- NCT06270030Lead sponsorPhase 1Mar 4, 2024
- NCT06183671Lead sponsorPhase 1Jan 1, 2024
- NCT06116968Lead sponsorPhase 3Nov 8, 2023
- NCT06045299Study directorPhase 3Sep 27, 2023
- NCT06045299Lead sponsorPhase 3Sep 27, 2023
- NCT05511870Lead sponsorPhase 1Mar 31, 2023
- NCT05511870Study directorPhase 1Mar 31, 2023
- NCT05576415Lead sponsorPhase 1Dec 7, 2022
- NCT05576415Study directorPhase 1Dec 7, 2022
- NCT05378945Lead sponsorPhase 3Jul 22, 2022
- NCT05378945Study directorPhase 3Jul 22, 2022
Details
- Founded
- Shanghai, CN Jun 1, 2019
- Last known activity
- Jun 17, 2025